Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098195
Filing Date
2024-11-14
Accepted
2024-11-14 13:44:46
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220817-10q_60degrees.htm   iXBRL 10-Q 1509063
2 CERTIFICATION ea022081701ex31-1_60degrees.htm EX-31.1 9932
3 CERTIFICATION ea022081701ex31-2_60degrees.htm EX-31.2 9788
4 CERTIFICATION ea022081701ex32-1_60degrees.htm EX-32.1 3984
5 CERTIFICATION ea022081701ex32-2_60degrees.htm EX-32.2 3960
  Complete submission text file 0001213900-24-098195.txt   8512186

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sxtp-20240930.xsd EX-101.SCH 78857
7 XBRL CALCULATION FILE sxtp-20240930_cal.xml EX-101.CAL 55794
8 XBRL DEFINITION FILE sxtp-20240930_def.xml EX-101.DEF 408956
9 XBRL LABEL FILE sxtp-20240930_lab.xml EX-101.LAB 734532
10 XBRL PRESENTATION FILE sxtp-20240930_pre.xml EX-101.PRE 411427
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0220817-10q_60degrees_htm.xml XML 988743
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 241460051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)